0000950103-15-000350.txt : 20150114 0000950103-15-000350.hdr.sgml : 20150114 20150114160512 ACCESSION NUMBER: 0000950103-15-000350 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150114 FILED AS OF DATE: 20150114 DATE AS OF CHANGE: 20150114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ISRAEL CHEMICALS LTD CENTRAL INDEX KEY: 0000941221 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13742 FILM NUMBER: 15527294 BUSINESS ADDRESS: STREET 1: MILLENNIUM TOWER STREET 2: 23 ARANHA STREET, P.O. BOX 20245 CITY: TEL AVIV STATE: L3 ZIP: 61202 BUSINESS PHONE: (972-3) 684-4400 MAIL ADDRESS: STREET 1: MILLENNIUM TOWER STREET 2: 23 ARANHA STREET, P.O. BOX 20245 CITY: TEL AVIV STATE: L3 ZIP: 61202 6-K 1 dp52613_6k.htm FORM 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934


For the month of January 2015
 
 
Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
X
  
Form 40-F
  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes
    
No
X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes
    
No
X

 
 
 
 
 
ISRAEL CHEMICALS LTD.

 
1.
Extraordinary General Meeting announcement dated January 14, 2015
 
 
 
 
 
 
Item 1

 
ICL Extraordinary General Meeting

 
The Company hereby wishes to report that it will convene an Extraordinary General Meeting on February 26, 2015, and that it has established January 27, 2015, as the record date to determine shareholders’ eligibility to vote.



Sincerely,
 
Israel Chemicals Ltd.
 
 
 
 
 
SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 

   
Israel Chemicals Ltd.
  
       
       
     
By:
/s/ Avi Doitchman
  
       
Name:
Avi Doitchman
  
       
Title:
Executive Vice President, Chief Financial Officer & Strategy
  

   
Israel Chemicals Ltd.
  
       
       
     
By:
/s/ Lisa Haimovitz
  
       
Name:
Lisa Haimovitz
  
       
Title:
Vice President, General Counsel and Corporate Secretary
  

Date: January 14, 2015